Resources

Coexistence of Autoimmune Encephalitis and Other Systemic Autoimmune Diseases February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6834766/

Learn more
A Tale of Two Brothers: Familial Voltage-Gated Potassium Channel Autoimmune Encephalitis February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7372199/

Learn more
Generate-Boost: study protocol for a prospective, multicenter, randomized controlled, double-blinded phase II trial to evaluate efficacy and safety of bortezomib in patients with severe autoimmune encephalitis February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7346383/

Learn more
Clinical approach to the diagnosis of autoimmune encephalitis in the pediatric patient February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7051207/

Learn more
Clinical and imaging features of children with autoimmune encephalitis and MOG antibodies February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217659/

Learn more
Associations between HLA and autoimmune neurological diseases with autoantibodies February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065322/

Learn more
Intravenous methylprednisolone or immunoglobulin for anti-glutamic acid decarboxylase 65 antibody autoimmune encephalitis: which is better? February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7106675/

Learn more
Figural Memory Impairment in Conjunction With Neuropsychiatric Symptoms in IgLON5 Antibody-Associated Autoimmune Encephalitis February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7351505/

Learn more
Psychiatric Manifestation of Anti-LGI1 Encephalitis February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348933/

Learn more
Seizures and risk of epilepsy in anti-NMDAR, anti-LGI1, and anti-GABABR encephalitis February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448167/

Learn more